BTA biota holdings limited

Biota Pharmaceuticals' CEO Dr. Joseph Patti Interviewed by The Life Sciences Report, page-8

  1. 8,256 Posts.
    Looks like they are hoping for and targeting an inflection point in 12-18 months time.

    Vapendavir may yet promise after re-targeted trials.

    Bottom drawer till then.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.